secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2025-10-22T23:59:59+00:00
Accession:  0001193125-25-245823
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ImageneBio CEO Kristin Yarema appointed interim principal financial officer
---------------------------------------------------------------------------

- Board appointed CEO Kristin Yarema as interim CFO effective Oct 21, 2025.
- Yarema previously served as CEO; biographical info referenced from Sept 2025 S-1 filing.
- No reason for the change or prior CFO departure disclosed in the filing.
- The appointment is effective immediately; Yarema continues as CEO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312525245823/0001193125-25-245823-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312525245823/d55570d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-245823

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer